Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7.
about
Design of a highly effective therapeutic HPV16 E6/E7-specific DNA vaccine: optimization by different ways of sequence rearrangements (shuffling).Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus typesDevelopment of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia.
P2860
Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7.
@en
Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7.
@nl
type
label
Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7.
@en
Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7.
@nl
prefLabel
Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7.
@en
Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7.
@nl
P2093
P1433
P1476
Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7
@en
P2093
F E Henken
J B A G Haanen
K Oosterhuis
P Öhlschläger
P304
P356
10.1016/J.VACCINE.2012.04.013
P407
P577
2012-04-30T00:00:00Z